These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4598722)

  • 1. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney repercussions of bile duct contrast media administration].
    Billis A; Dimopoulos C; Giamarellou H; Zoubouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daikos G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):447-50. PubMed ID: 4804417
    [No Abstract]   [Full Text] [Related]  

  • 3. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 4. Uricosuria and x-ray contrast agents.
    Kelley WN
    N Engl J Med; 1971 Apr; 284(17):975-6. PubMed ID: 5573284
    [No Abstract]   [Full Text] [Related]  

  • 5. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 6. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations.
    Postlethwaite AE; Kelley WN
    Ann Intern Med; 1971 Jun; 74(6):845-52. PubMed ID: 5580635
    [No Abstract]   [Full Text] [Related]  

  • 7. Results obtained in comparative radiographie, clinical and clinical-chemical studies in iocetamic acid (DRC 1201) and iopanoic acid.
    Hekster RE
    Radiol Clin Biol; 1968; 37(6):338-52. PubMed ID: 5714064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Uricosuric effect of radiologic contrast media].
    Peña Yañez A; Raya Muñóz J; Mora Lara RJ; Hervas Sanchez JG; Peinado CA
    Rev Clin Esp; 1976 Dec; 143(6):567-74. PubMed ID: 796907
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute renal failure caused by iodinated contrast material].
    Torras J; Martínez Castelao A; Romero R; Alsina J
    Med Clin (Barc); 1985 May; 84(19):772-6. PubMed ID: 4033249
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abdominal angiography with high doses of contrast media. Action on kidney functions and clinical considerations (author's transl)].
    Passariello R; Rossi P; Simonetti G; Ciolina A
    Ann Radiol (Paris); 1978; 21(6):481-4. PubMed ID: 736454
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical trial of oral cholecystographic agents: telepaque, sodium oragrafin and calcium oragrafin.
    Tishler JM; Gold R
    J Can Assoc Radiol; 1969 Jun; 20(2):102-5. PubMed ID: 5793435
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholecystography and renal failure.
    Lancet; 1971 Jul; 2(7716):146-7. PubMed ID: 4104470
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trial of Bilivistan, a new contrast medium for cholecystography].
    Bång I
    Nord Med; 1967 Jul; 78(30):970-1. PubMed ID: 5339533
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent.
    Canales CO; Smith GH; Robinson JC; Remmers AR; Sarles HE
    N Engl J Med; 1969 Jul; 281(2):89-91. PubMed ID: 5784785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects in man of an injection of a new contrast medium for cholangiography].
    Ambrosioni E; Catizone L; Chiarini C; Costa V; Perri G
    G Clin Med; 1972 Mar; 53(3):132-41. PubMed ID: 4567883
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiopaque contrast media. XXVII. Pharmacologic properties of iodoxamic acid, a new contrast medium for intravenous cholegraphy.
    Rosati G; Schiantarelli P; Tirone P
    Farmaco Sci; 1973 Dec; 28(12):996-1010. PubMed ID: 4765762
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of drugs on the uptake of uric acid by separated renal tubules of the rabbit.
    Kippen I; Klinenberg JR
    Adv Exp Med Biol; 1977; 76B():114-6. PubMed ID: 855739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.